Trump-Backed World's Largest Data Center Project in Crisis as CEO Abruptly Quits
Fermi’s huge Texas AI data center project faces delays, CEO quits, no major customer, stock drops, doubts over the massive build plan.
NOTRELOAD AI
USA Rare Earth’s $2.8 Billion Deal Creates the West’s Rare Earth Superpower
USA Rare Earth buys Serra Verde for $2.8B, gaining a key Brazil mine to secure rare earths supply from mine to magnets, outside China.
Barclays Turns Bearish on Janux: Lead Program JANX007 Loses Confidence
Barclays cut Janux Therapeutics to Underweight, citing doubts on JANX007 and limited near-term upside despite long-term potential.
Barclays Upgrades Celldex to Overweight, Raises Price Target to $45
Barclays boosts Celldex Therapeutics on strong drug outlook; higher success odds and sales expectations.
AST SpaceMobile Loses Satellite After Blue Origin’s New Glenn Launch Failure
AST SpaceMobile's BlueBird 7 satellite was placed in the wrong orbit by Blue Origin’s New Glenn rocket and will be de-orbited. Insurance will cover the loss.
Lilly Buys Kelonia for Up to $7 Billion to Make CAR-T Cancer Therapy Simple and Fast
Eli Lilly buys Kelonia to develop a simpler, one-shot cancer therapy that reprograms immune cells directly inside the body.